Advertisement

Should We Optimize Antiretroviral CNS Penetration for Patients with HIV-Associated Neurologic Disease?

Summary and Comment |
February 3, 2014

Should We Optimize Antiretroviral CNS Penetration for Patients with HIV-Associated Neurologic Disease?

Advertisement